Market Value425,474,000
Total Holdings50
File Date2021-08-11
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
QQQ / Invesco QQQ Trust, Series 1
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
FATE / Fate Therapeutics, Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
VTGN / Vistagen Therapeutics, Inc.
XENE / Xenon Pharmaceuticals Inc.
OTIC / Otonomy Inc
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
EPIX / ESSA Pharma Inc.
859319303 / Sterling Financial Corp
US33830X1046 / Five Prime Therapeutics Inc
WVE / Wave Life Sciences Ltd.
US2103731061 / Constellation Pharmaceuticals Inc
ARKG / ARK ETF Trust - ARK Genomic Revolution ETF Put
KDMN / Kadmon Holdings Inc
DTIL / Precision BioSciences, Inc.
KURA / Kura Oncology, Inc.
CBIO / Crescent Biopharma, Inc.
CRIS / Curis, Inc.
MRSN / Mersana Therapeutics, Inc.
SURF / Surface Oncology Inc
ACRS / Aclaris Therapeutics, Inc.
CASI / CASI Pharmaceuticals, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
IWM / iShares Trust - iShares Russell 2000 ETF
TRIL / Trillium Therapeutics Inc
IMVT / Immunovant, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
TPST / Tempest Therapeutics, Inc.
APLS / Apellis Pharmaceuticals, Inc.
KALV / KalVista Pharmaceuticals, Inc.
FREQ / Frequency Therapeutics Inc Put
MRTX / Mirati Therapeutics, Inc. Call
BIIB / Biogen Inc.
CMRX / Chimerix, Inc.
ALDX / Aldeyra Therapeutics, Inc.
QQQ / Invesco QQQ Trust, Series 1 Put
SRRA / Sierra Oncology Inc
IMUX / Immunic, Inc.
IOVA / Iovance Biotherapeutics, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
APVO / Aptevo Therapeutics Inc.
MRNA / Moderna, Inc. Put
MRTX / Mirati Therapeutics, Inc.
TVTX / Travere Therapeutics, Inc.
MLTX / MoonLake Immunotherapeutics
NVAX / Novavax, Inc.
ISEE / IVERIC bio Inc
CLDX / Celldex Therapeutics, Inc. Put
CLDX / Celldex Therapeutics, Inc.
SAGE / Sage Therapeutics, Inc.
FGEN / FibroGen, Inc.
SRPT / Sarepta Therapeutics, Inc.
NUVB / Nuvation Bio Inc.
CTIC / CTI BioPharma Corp
SNDX / Syndax Pharmaceuticals, Inc.
FOLD / Amicus Therapeutics, Inc.
COGT / Cogent Biosciences, Inc.
TGTX / TG Therapeutics, Inc.
ARVN / Arvinas, Inc.
VRDN / Viridian Therapeutics, Inc.